Artemis Therapeutics Inc.

$0.50-73.65%($-1.39)
TickerSpark Score
39/100
Weak
47
Valuation
60
Profitability
15
Growth
24
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATMS research report →

52-Week Range9% of range
Low $0.11
Current $0.50
High $4.50

Companywww.artemis-therapeutics.com

Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases.

CEO
Shimon Citron
IPO
1998
Employees
4
HQ
New York City, NY, US

Price Chart

-82.02% · this period
$4.60$2.39$0.17May 13Nov 11May 25

Valuation

Market Cap
$55.79M
P/E
-21032.59
P/S
179.40
P/B
-27694.96
EV/EBITDA
-41.77
Div Yield
0.00%

Profitability

Gross Margin
82.64%
Op Margin
-436.98%
Net Margin
-434.41%
ROE
177.53%
ROIC
213.72%

Growth & Income

Revenue
$311.00K · 0.00%
Net Income
$-1,351,000 · -650.56%
EPS
$-0.01 · -44.93%
Op Income
$-1,359,000
FCF YoY
-469.86%

Performance & Tape

52W High
$4.50
52W Low
$0.11
50D MA
$0.48
200D MA
$1.25
Beta
0.00
Avg Volume
1.53K

Get TickerSpark's AI analysis on ATMS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Jun 30, 22CITRON SHIMONother0
Jun 30, 22CITRON SHIMONother0
Jun 30, 22CITRON SHIMONother32,772,000
Jun 30, 22CITRON SHIMONother21,848,400
Jul 26, 22Dana Davidother0
Dec 18, 18Peleg Gadisell182
Mar 15, 18Culley Brian Mother48,528
Mar 15, 18Morris Chananother50,000
Oct 23, 17Culley Brian Mbuy25,000
Oct 23, 17Culley Brian Mbuy12,500

Our ATMS Coverage

We haven't published any research on ATMS yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate ATMS Report →

Similar Companies